Loading clinical trials...
Loading clinical trials...
A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Treatment Effect of GBT440 in Pediatric Participants With Sickle Cell Disease
Conditions
Interventions
Voxelotor
Locations
20
United States
Brentwood Clinic UCSF Benioff Children's Hospital Oakland
Brentwood, California, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Children's Healthcare of Atlanta Scottish Rite
Atlanta, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
University of Illinois at Chicago Clinical Research Center
Chicago, Illinois, United States
Our Lady of the Lake Children's Hospital (IP Address)
Baton Rouge, Louisiana, United States
Start Date
July 5, 2016
Primary Completion Date
October 2, 2023
Completion Date
October 2, 2023
Last Updated
August 15, 2025
NCT06612268
NCT06820515
NCT07392216
NCT07187973
NCT04416178
NCT05359991
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions